Integrum publishes year-end report for 2025/2026
Net sales 91.4 MSEK, operating result -53.2 MSEK, affected by non-recurring items.
See the latest news and media coverage for Integrum. We track all announcements, press releases, and industry mentions in real time, all in one place.
Specialist in osseointegration for amputees
integrum.seLast updated
In short: Integrum announced plans to consolidate its bionics operations under the name Afyri and reported a net loss for the 2025/2026 fiscal year.
Net sales 91.4 MSEK, operating result -53.2 MSEK, affected by non-recurring items.
The proposal outlines a two-year pilot covering surgery, rehabilitation, and implant funding, with first patients expected by late 2026.
The implant uses the OPRA Implant System and has been shown in an SVT segment with an interview.
The patient portal supports the patient journey and the IR platform provides transparent information to shareholders. The goal is increased growth and broader use of implants.
Mölndal, Sweden, June 16, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has received an initial...
Mölndal, Sweden, June 9, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that it intends to consolidate all operations...
Mölndal, Sweden, April 30, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that, as part of preparing the annual...
Mölndal, Sweden, April 15, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Victoria Boiko to coordinate...
Track Integrum and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.